LUNA MEDICAL TECHNOLOGIES INC
10QSB, EX-27, 2000-12-21
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: LUNA MEDICAL TECHNOLOGIES INC, 10QSB, EX-10.3, 2000-12-21
Next: ICHARGEIT INC, 10KSB, 2000-12-21



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                            2,395
<SECURITIES>                                          0
<RECEIVABLES>                                    12,946
<ALLOWANCES>                                     (1,334)
<INVENTORY>                                           0
<CURRENT-ASSETS>                                 23,055
<PP&E>                                            2,543
<DEPRECIATION>                                     (632)
<TOTAL-ASSETS>                                   27,357
<CURRENT-LIABILITIES>                           363,351
<BONDS>                                               0
                                 0
                                           0
<COMMON>                                          8,156
<OTHER-SE>                                     (344,150)
<TOTAL-LIABILITY-AND-EQUITY>                     27,357
<SALES>                                          36,883
<TOTAL-REVENUES>                                 36,883
<CGS>                                            24,676
<TOTAL-COSTS>                                         0
<OTHER-EXPENSES>                                385,056
<LOSS-PROVISION>                                      0
<INTEREST-EXPENSE>                                  109
<INCOME-PRETAX>                                (372,671)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                            (372,671)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                   (372,671)
<EPS-BASIC>                                        (.05)
<EPS-DILUTED>                                      (.05)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission